New hope for breast cancer patients with brain lining spread: High-Dose methotrexate trial underway

NCT ID NCT02422641

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a high dose of the chemotherapy drug methotrexate given through a vein in people with breast cancer that has spread to the lining of the brain. The goal is to see if it helps them live longer. The trial includes adults with triple-negative, HER2-positive, or hormone-resistant breast cancer who have this specific type of brain involvement.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma breast neoplasm Meningeal Neoplasms neoplastic meningitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Comprehensive Cancer Center at Wake Forest University (CCCWFU)

    RECRUITING

    Winston-Salem, North Carolina, 27157, United States

    Contact Email: •••••@•••••

  • Sidney Kimmel Comprehensive Cancer Center

    RECRUITING

    Baltimore, Maryland, 21287, United States

    Contact Email: •••••@•••••

  • Siteman Cancer Center- Washington University School of Medicine in St. Louis

    ACTIVE_NOT_RECRUITING

    St Louis, Missouri, 63130, United States